Prevalence of schizophrenia spectrum and bipolar disorder among patients with cannabis induced psychosis: a systematic review and meta-analysis.
Distinguishing cannabis-induced psychosis from primary psychiatric disorders is difficult and has significant clinical and prognostic implications. Current t...
Endocannabinoid System and Psychotic Disorders: Clinical
Clinical Takeaway Cannabis-induced psychosis frequently precedes diagnosis of schizophrenia spectrum or bipolar disorder, with patients requiring careful long-term psychiatric monitoring rather than reassurance about symptom resolution. The overlap…
Endocannabinoid System and Psychosis Risk: Clinical Evidence
Clinical Takeaway Cannabis-induced psychosis increases the risk of subsequently developing schizophrenia spectrum and bipolar disorder, with prevalence rates varying significantly across studies. Patients experiencing cannabis-induced psychosis require…
Endocannabinoid System Psychosis Risk: Clinical Research Guide
Clinical Takeaway Clinical Takeaway Patients presenting with cannabis-induced psychosis have measurable risk for developing schizophrenia spectrum or bipolar disorder, though distinguishing these primary psychiatric conditions from acute cannabis effects…
Endocannabinoid System Clinical Research on Psychosis Risk
Clinical Takeaway Patients who experience cannabis-induced psychosis have a documented risk of subsequently developing schizophrenia spectrum or bipolar disorder, with prevalence varying across studies due to differences in follow-up duration and…
`Cannabis Psychosis to Schizophrenia: Clinical Evidence Review`
Clinical Takeaway A significant portion of people diagnosed with cannabis-induced psychosis go on to develop schizophrenia spectrum or bipolar disorder over time. Clinicians should treat cannabis-induced psychosis as a serious warning sign rather than a…
`Cannabis-Induced Psychosis & Schizophrenia Risk: Key Research`
Clinical Takeaway A significant portion of patients diagnosed with cannabis-induced psychosis go on to develop a primary psychiatric disorder such as schizophrenia spectrum disorder or bipolar disorder over time. Clinicians should treat cannabis-induced…
`Cannabis-Induced Psychosis and Psychotic Disorders: Key Evidence`
Clinical Takeaway A significant proportion of patients diagnosed with cannabis-induced psychosis go on to develop schizophrenia spectrum or bipolar disorder over time. Clinicians should treat cannabis-induced psychosis as a serious warning sign that…
New study shows cannabis can distort reality through false memories – Pakistan Today
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic NewStudyShowsCannabis Why This…
Potent Pot Fuels Psychotic Episodes, ER Visits: ‘America Has a Marijuana Problem’ – CBN
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthThcEmergency…